ED
MS icon

Exane Derivatives’s Morgan Stanley MS Stock Holding History

Exane Derivatives’s Portfolio MS Stock Details MS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$76 Hold
1
– – ﹤0.01% 730
2022
Q1 		$87 Sell
1
-1,132
-100% -$109K ﹤0.01% 995
2021
Q4 		$111K Sell
1,133
-5,600
-83% -$558K 0.03% 429
2021
Q3 		$655K Buy
6,733
+453
+7% +$44.9K 0.16% 139
2021
Q2 		$585K Buy
6,280
+153
+2% +$13.1K 0.13% 155
2021
Q1 		$476K Sell
6,127
-559
-8% -$42.8K 0.14% 155
2020
Q4 		$458K Buy
6,686
+5,336
+395% +$306K 0.13% 177
2020
Q3 		$65.3K Sell
1,350
-11,475
-89% -$578K 0.02% 355
2020
Q2 		$619K Buy
12,825
+3,240
+34% +$136K 0.17% 113
2020
Q1 		$326K Sell
9,585
-2,644
-22% -$125K 0.09% 152
2019
Q4 		$647K Sell
12,229
-2,568
-17% -$122K 0.12% 136
2019
Q3 		$631K Sell
14,797
-7,200
-33% -$308K 0.11% 144
2019
Q2 		$963K Buy
21,997
+8,164
+59% +$364K 0.17% 106
2019
Q1 		$584K Buy
13,833
+3,051
+28% +$128K 0.12% 144
2018
Q4 		$427K Sell
10,782
-700
-6% -$30.5K 0.08% 191
2018
Q3 		$541K Buy
11,482
+9,625
+518% +$470K 0.1% 154
2018
Q2 		$89.7K Sell
1,857
-332
-15% -$17.3K 0.02% 347
2018
Q1 		$115K Buy
2,189
+210
+11% +$11.6K 0.02% 283
2017
Q4 		$104K Buy
1,979
+1,489
+304% +$75.3K 0.02% 293
2017
Q3 		$23.6K Buy
+490
New +$22.7K ﹤0.01% 349
2016
Q4 		– Sell
-10,582
Closed -$339K – 672
2016
Q3 		$339K Sell
10,582
-61,585
-85% -$1.84M 0.05% 173
2016
Q2 		$1.87M Buy
72,167
+16,585
+30% +$434K 0.31% 55
2016
Q1 		$1.39M Buy
55,582
+11,668
+27% +$298K 0.18% 74
2015
Q4 		$1.4M Sell
43,914
-30,042
-41% -$998K 0.19% 70
2015
Q3 		$2.33M Buy
73,956
+64,568
+688% +$2.35M 0.29% 60
2015
Q2 		$364K Buy
9,388
+4,931
+111% +$188K 0.04% 163
2015
Q1 		$159K Sell
4,457
-1,137
-20% -$40.8K 0.02% 223
2014
Q4 		$217K Buy
+5,594
New +$199K 0.03% 203

Other funds holding MS

Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $78.8B AUM 48.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's MS Position: Q2 2022 in Review

Exane Derivatives held its Morgan Stanley (MS) position steady in Q2 2022 at 1 share worth $76. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Exane Derivatives first reported a position in MS in Q4 2014 and has held it in 28 quarters since. The position peaked at $2.33M in Q3 2015. 1,603 funds tracked by Wall St. Rank hold MS as of Q2 2022.

  • Exane Derivatives held 1 share of Morgan Stanley worth $76 as of Q2 2022.
  • Exane Derivatives left its Morgan Stanley share count unchanged in Q2 2022.
  • Morgan Stanley made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #730 holding.
  • Exane Derivatives first reported a position in Morgan Stanley in Q4 2014 and has held it in 28 quarters since.
  • Exane Derivatives's Morgan Stanley position peaked at $2.33M in Q3 2015.
  • 1,603 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.